
The Zhitong Finance App learned that China Heart Link Chemical Fertilizer (01866) rose by more than 6%. As of press release, it had risen 5.22% to HK$9.47, with a turnover of HK$265.304 million.
According to the news, China Xinlianxin Chemical announced that it achieved operating revenue of 23.047 billion yuan in the first three quarters of 2026, an increase of 28% over the previous year; net profit to mother was 1,138 billion yuan, an increase of 42% over the previous year. Looking at the third quarter, the group successfully completed maintenance work at each base. Furthermore, through process optimization and automation system upgrades, the automatic control rate of the device has been raised to 90%, reaching the reference standard for smart factories, laying the foundation for stable production at full load. In the third quarter, the Group achieved revenue of about 7.307 billion yuan, an increase of 38% over the previous year, and net profit to mother of about 217 million yuan, an increase of 8% over the previous year. During the period, urea production increased by 780,000 tons year on year, sales of high-efficiency urea increased 17% year on year, urea exports increased by nearly 100,000 tons year on year, and gross profit of chemical products increased by 650 million yuan year on year, an increase of 77%.
It is worth mentioning that China Heart Link Fertilizer announced that the board of directors has decided to adopt the share incentive plan. The plan aims to strengthen the long-term value binding between core participants and the Group through share rewards, deepen recognition of the Group's strategic layout and corporate culture, work together to build a century-old foundation to support the Group's long-term sustainable operation; recognize and commend the contributions and rewards of several eligible participants to the Group's growth and development in order to retain their continued effectiveness for the Group's continued operation and development; and attract suitable talents for the Group's further development.